Maged Khalil

2.2k total citations
24 papers, 516 citations indexed

About

Maged Khalil is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Maged Khalil has authored 24 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Maged Khalil's work include Cancer Immunotherapy and Biomarkers (8 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Genomics and Diagnostics (4 papers). Maged Khalil is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Genomics and Diagnostics (4 papers). Maged Khalil collaborates with scholars based in United States, Canada and Australia. Maged Khalil's co-authors include Vedene H. Smith, Robert J. Woods, Steven Moffat, William D. Wagner, Ira J. Goldberg, Donald F. Weaver, Richard L. Schilsky, Elizabeth Garrett‐Mayer, Susan Halabi and Timothy Lewis Cannon and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Maged Khalil

24 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maged Khalil United States	9	176	140	115	93	75	24	516
Tadashi Murase Japan	11	178 1.0×	254 1.8×	122 1.1×	51 0.5×	55 0.7×	24	712
Jiaxing Lin China	15	113 0.6×	278 2.0×	180 1.6×	144 1.5×	61 0.8×	54	693
Lei Shen China	16	97 0.6×	177 1.3×	47 0.4×	50 0.5×	55 0.7×	39	987
François Guérard France	19	274 1.6×	137 1.0×	243 2.1×	44 0.5×	65 0.9×	40	1.0k
J. Ferreira Belgium	9	105 0.6×	259 1.9×	292 2.5×	81 0.9×	89 1.2×	15	685
Hongsheng Tang China	16	107 0.6×	363 2.6×	78 0.7×	261 2.8×	171 2.3×	36	824
Oswald Burkhard Germany	10	226 1.3×	58 0.4×	120 1.0×	24 0.3×	45 0.6×	30	663
Cécile Combeau France	13	339 1.9×	431 3.1×	156 1.4×	93 1.0×	28 0.4×	22	1.0k
F. Brady United Kingdom	16	64 0.4×	154 1.1×	90 0.8×	97 1.0×	35 0.5×	39	732
Yen-Lin Lin Taiwan	8	57 0.3×	235 1.7×	24 0.2×	53 0.6×	38 0.5×	12	474

Countries citing papers authored by Maged Khalil

Since Specialization

Citations

This map shows the geographic impact of Maged Khalil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maged Khalil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maged Khalil more than expected).

Fields of papers citing papers by Maged Khalil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maged Khalil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maged Khalil. The network helps show where Maged Khalil may publish in the future.

Co-authorship network of co-authors of Maged Khalil

This figure shows the co-authorship network connecting the top 25 collaborators of Maged Khalil. A scholar is included among the top collaborators of Maged Khalil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maged Khalil. Maged Khalil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yost, Kathleen J., Michael Rothe, Pam K. Mangat, et al.. (2024). Talazoparib (Tala) in patients (pts) with colorectal cancer (CRC) with BRCA1/2 mutations (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.. Journal of Clinical Oncology. 42(3_suppl). 106–106. 1 indexed citations

Rivero, Jaydira Del, Kimberly Perez, Susan M. Geyer, et al.. (2023). Alliance A021804: A prospective, multi-institutional phase II trial evaluating temozolomide versus temozolomide and olaparib for advanced pheochromocytoma and paraganglioma.. Journal of Clinical Oncology. 41(16_suppl). TPS4191–TPS4191. 2 indexed citations

Vaccaro, Gina M., Michael Rothe, Pam K. Mangat, et al.. (2022). Nivolumab plus ipilimumab (N+I) in patients (pts) with colorectal cancer (CRC) with high tumor mutational burden (hTMB): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.. Journal of Clinical Oncology. 40(4_suppl). 107–107. 7 indexed citations

Yoon, Harry H., Fang‐Shu Ou, Gamini S. Soori, et al.. (2021). Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance]). European Journal of Cancer. 150. 214–223. 13 indexed citations

Alva, Ajjai, Pam K. Mangat, Elizabeth Garrett‐Mayer, et al.. (2021). Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. Journal of Clinical Oncology. 39(22). 2443–2451. 116 indexed citations

Funt, Samuel A., Michael Lattanzi, Karissa Whiting, et al.. (2021). Neoadjuvant atezolizumab (A) with gemcitabine and cisplatin (GC) in patients (pts) with muscle-invasive bladder cancer (MIBC): A multicenter, single-arm, phase 2 trial.. Journal of Clinical Oncology. 39(15_suppl). 4517–4517. 7 indexed citations

Khalil, Maged, et al.. (2020). Neoadjuvant Immunotherapy in Microsatellite-Instability High Nonmetastatic Colorectal Cancer: A Single-institute Experience and Review of the Literature. Clinical Colorectal Cancer. 20(2). e109–e112. 3 indexed citations

Chae, Young Kwang, Megan Othus, Sandip Pravin Patel, et al.. (2020). Abstract 3417: A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: The small bowel tumor cohort. Cancer Research. 80(16_Supplement). 3417–3417. 5 indexed citations

Huddart, Robert, Arlene O. Siefker‐Radtke, Arjun Vasant Balar, et al.. (2020). PIVOT-10: Phase II study of bempegaldesleukin plus nivolumab in cisplatin-ineligible advanced urothelial cancer. Future Oncology. 17(2). 137–149. 6 indexed citations

10.

Huddart, Robert, Arlene O. Siefker‐Radtke, Arjun Vasant Balar, et al.. (2020). PIVOT-10: A phase II study of bempegaldesleukin (NKTR-214) in combination with nivolumab (NIVO) in cisplatin (cis) ineligible patients with previously untreated locally advanced or metastatic urothelial cancer (mUC).. Journal of Clinical Oncology. 38(6_suppl). TPS589–TPS589. 1 indexed citations

11.

Johnson, Benny, Maged Khalil, Joseph Blansfield, et al.. (2016). Investigating the prognostic value of KOC (K homology domain containing protein overexpressed in cancer) overexpression after curative intent resection of pancreatic ductal adenocarcinoma. Journal of Gastrointestinal Oncology. 6(7). E113–E117. 5 indexed citations

12.

Alberts, Steven R., Gamini S. Soori, Qian Shi, et al.. (2013). Randomized phase II trial of extended versus standard neoadjuvant therapy for esophageal cancer, NCCTG (Alliance) trial N0849.. Journal of Clinical Oncology. 31(15_suppl). 4026–4026. 6 indexed citations

13.

Khalil, Maged, et al.. (2006). High Dose Glucocorticoids Potentiate the Reponse to Erythropoietin.. Blood. 108(11). 3775–3775. 1 indexed citations

14.

Khalil, Maged, et al.. (2005). Epithelioid Angiosarcoma of the Small Intestine After OccupationalExposure to Radiation and Polyvinyl Chloride: A case Report and Review of Literature. Sarcoma. 9(3-4). 161–164. 25 indexed citations

15.

Khalil, Maged, et al.. (2005). Hepatocellular carcinoma in an African American man with a noncirrhotic liver presented initially as an occipital mass.. PubMed. 3(7). 574–7; discussion 577. 1 indexed citations

16.

Weaver, Donald F., Maged Khalil, & Vedene H. Smith. (1991). An AMI semi-empirical quantum mechanical study of the polyhydration of amino acid side chains. Journal of Molecular Structure THEOCHEM. 226(1-2). 73–86. 5 indexed citations

17.

Khalil, Maged, Robert J. Woods, Donald F. Weaver, & Vedene H. Smith. (1991). An examination of intermolecular and intramolecular hydrogen bonding in biomolecules by AM1 and MNDO/M semiempirical molecular orbital studies. Journal of Computational Chemistry. 12(5). 584–593. 42 indexed citations

18.

Woods, Robert J., et al.. (1990). Derivation of net atomic charges from molecular electrostatic potentials. Journal of Computational Chemistry. 11(3). 297–310. 139 indexed citations

19.

Khalil, Maged & Donald F. Weaver. (1990). A pattern recognition study of acyclic ureide anticonvulsants. Journal of Pharmacy and Pharmacology. 42(5). 349–351. 5 indexed citations

20.

Yang, Kiyull, et al.. (1988). Conformation–activity relationships and the mechanism of action of penicillin. Canadian Journal of Chemistry. 66(11). 2733–2750. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact